Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Johnson & Johnson

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



journal of oncology practice1 - radiation nephritis1 - prostate cancer survival1 - myxedema1 - anorexia1 - onset1 - abdominopelvic cavity1 - birth weight1 - intravenous fluids1 - renal colic3 - kidney donor2 - testis-determining gene1 - urethral pain1 - stress urinary incontinence1 - renal vein1 - measuring psa1 - creatinine levels1 - robotic-assisted bladder operations1 - anorectal canal1 - american society for radiation oncology4 - prostate cancer etiology1 - triage1 - osteomalacia2 - hemodiafiltration1 - pyonephrosis1 - the endocrine society's journal of clinical endocrinology & metabolism1 - nephritis1 - tras1 - urine test3 - radical treatment1 -